£113.76

This is the most expensive it has ever been. Walk away.

£114 today · previous high £114 · all-time low £108

Humana Farnesyltransferase Inhibitors in Cancer Therapy (Cancer Drug Discovery and Development)

Amazon

Price History & Forecast

Grey patches = out of stock. Cheaper = lower on the chart. Hover for exact prices.

Last 64 days · 64 data points (no recent data)

Historical
Generating forecast…
£113.76 £107.44 £108.82 £110.20 £111.58 £112.96 £114.34 22 August 2026 06 September 2026 22 September 2026 08 October 2026 24 October 2026
View at Amazon ↗

Price data last checked 27 day(s) ago - will refresh soon

NEW HERE?

Amazon shows you one price. We show you all of them.

Tosheroon watches Amazon prices so you don't have to. Every product on Amazon has a price history — we make it visible. Set the price you'd actually pay, and we'll email you the second it gets there. No app, no account, one email.

WHAT'S ON THIS PAGE

↑ Price chart
when this has been cheap or pricey
↑ Forecast
where the price is heading next
↓ Statistics
all-time high & low, recent range
↑ Price alert
name your number, we'll email you

Price Distribution

Price distribution over 64 days • 2 price levels

Days at Price
Current Price
35 days 29 days · current 0 9 18 26 35 £108 £114 Days at Price

Price Analysis

Most common price: £108 (35 days, 54.7%)

Price range: £108 - £114

Price levels: 2 different prices over 64 days

Description

Cutting-edge researchers describe their efforts to design, synthesize, and evaluate the biological activities of farensyltransferase inhibitors (FTIs); geranylgeranyltransferase inhibitors (GGTIs) are also discussed as potential anticancer drugs. The authors survey in detail such inhibitors as CAAX box peptidomimetics, FPP mimics, and bisubstrate transition state analogs, and critically review their uses in combination with radiation and other cytotoxic agents, such as gemcitabine, cisplatin, and taxanes. Illuminating and richly detailed, Farnesyltransferase Inhibitors in Cancer Therapy constitutes today's standard reference for the pathbreaking use of FTIs and GGTIs in anticancer therapy and offers basic and clinical investigators a comprehensive treatment of the scientific and medical aspects of farnesyltransferase inhibitors. From the Back Cover With the explosion of research on genes capable of causing cancer, it has become clear that mutations in the GTPase, Ras, a major regulator of cell division, are found in about 30% of all human cancers, and that farnesylation, a lipid posttranslational modification of Ras, is required for its cancer-causing activity. In Farnesyltransferase Inhibitors in Cancer Therapy, cutting-edge researchers describe their efforts to design, synthesize, and evaluate the biological activities of farnesyltransferase inhibitors (FTIs) and geranylgeranyltransferase inhibitors (GGTIs) that can be used as anticancer drugs and in cardiovascular and parasitic therapy. The authors survey in detail such inhibitors as CAAX box peptidomimetics, FPP mimics, and bisubstrate transition state analogs, and critically review their uses in combination with radiation and other cytotoxic agents, such as gemcitabine, cisplatin, and taxanes. The book also discusses the results from several phase I and II human clinical trials using a variety of FTIs, and demonstrates the design of hypothesis-driven clinical trials with proof-of-concept using biochemical endpoints. Illuminating and richly detailed, Farnesyltransferase Inhibitors in Cancer Therapy constitutes today's standard reference for the pathbreaking use of FTIs and GGTIs in anticancer therapy and offers basic and clinical investigators a comprehensive treatment of the scientific and medical aspects of farnesyltransferase inhibitors.

Product Specifications

Brand
Humana
Format
paperback
Domain
Amazon UK
Publication Date
26 November 2012
Listed Since
09 August 2013

Barcode

No barcode data available

Similar Products You Might Like

DNA Repair in Cancer Therapy (Cancer Drug Discovery and Development)
83% match

DNA Repair in Cancer Therapy (Cancer Drug Discovery and Development)

Humana

£113.76 25 Oct 2026
Nucleic Acid Therapeutics in Cancer (Cancer Drug Discovery and Development)
83% match

Nucleic Acid Therapeutics in Cancer (Cancer Drug Discovery and Development)

Humana

£73.14 24 Oct 2026
Genomics and Pharmacogenomics in Anticancer Drug Development and Clinical Response (Cancer Drug Discovery and Development)
83% match

Genomics and Pharmacogenomics in Anticancer Drug Development and Clinical Response (Cancer Drug Discovery and Development)

Humana

£141.86 24 Oct 2026
STAT Inhibitors in Cancer (Cancer Drug Discovery and Development)
82% match

STAT Inhibitors in Cancer (Cancer Drug Discovery and Development)

Humana

£112.02 31 Oct 2026
Advances in DNA Repair in Cancer Therapy (Cancer Drug Discovery and Development)
82% match

Advances in DNA Repair in Cancer Therapy (Cancer Drug Discovery and Development)

Humana

£144.51 23 Oct 2026
Natural Products and Cancer Drug Discovery (Cancer Drug Discovery and Development)
82% match

Natural Products and Cancer Drug Discovery (Cancer Drug Discovery and Development)

Humana

£109.35 22 Oct 2026
Molecular Targeting in Oncology (Cancer Drug Discovery and Development)
82% match

Molecular Targeting in Oncology (Cancer Drug Discovery and Development)

Humana

£148.21 22 Oct 2026
Targets for Cancer Chemotherapy: Transcription Factors and Other Nuclear Proteins (Cancer Drug Discovery and Development)
81% match

Targets for Cancer Chemotherapy: Transcription Factors and Other Nuclear Proteins (Cancer Drug Discovery and Development)

Humana

£77.77 24 Oct 2026
Anticancer Drug Development Guide: Preclinical Screening, Clinical Trials, and Approval (Cancer Drug Discovery and Development)
81% match

Anticancer Drug Development Guide: Preclinical Screening, Clinical Trials, and Approval (Cancer Drug Discovery and Development)

Humana

£76.42 23 Oct 2026
Insulin-like Growth Factors and Cancer: From Basic Biology to Therapeutics (Cancer Drug Discovery and Development)
81% match

Insulin-like Growth Factors and Cancer: From Basic Biology to Therapeutics (Cancer Drug Discovery and Development)

Humana

£109.07 23 Oct 2026
Gene and Cellular Immunotherapy for Cancer (Cancer Drug Discovery and Development)
81% match

Gene and Cellular Immunotherapy for Cancer (Cancer Drug Discovery and Development)

Humana

£113.77 30 Oct 2026
Nuclear Signaling Pathways and Targeting Transcription in Cancer (Cancer Drug Discovery and Development)
81% match

Nuclear Signaling Pathways and Targeting Transcription in Cancer (Cancer Drug Discovery and Development)

Humana

£108.01 23 Oct 2026
Increasing the Therapeutic Ratio of Radiotherapy (Cancer Drug Discovery and Development)
80% match

Increasing the Therapeutic Ratio of Radiotherapy (Cancer Drug Discovery and Development)

Humana

£114.71 23 Oct 2026
Antifolate Drugs in Cancer Therapy (Cancer Drug Discovery and Development)
80% match

Antifolate Drugs in Cancer Therapy (Cancer Drug Discovery and Development)

Humana

£148.21 24 Oct 2026
In Vivo Imaging of Cancer Therapy (Cancer Drug Discovery and Development)
80% match

In Vivo Imaging of Cancer Therapy (Cancer Drug Discovery and Development)

Humana

£80.65 21 Oct 2026
Pharmaceutical Perspectives of Cancer Therapeutics
80% match

Pharmaceutical Perspectives of Cancer Therapeutics

Springer

£179.99 27 Oct 2026
Drug Delivery Systems in Cancer Therapy (Cancer Drug Discovery and Development)
80% match

Drug Delivery Systems in Cancer Therapy (Cancer Drug Discovery and Development)

Humana

£165.10 24 Oct 2026
Transforming Growth Factor-Beta in Cancer Therapy, Volume I: Basic and Clinical Biology: 1 (Cancer Drug Discovery and Development)
80% match

Transforming Growth Factor-Beta in Cancer Therapy, Volume I: Basic and Clinical Biology: 1 (Cancer Drug Discovery and Development)

Humana

£98.07 03 Nov 2026
Integrin Targeting Systems for Tumor Diagnosis and Therapy (Methods in Pharmacology and Toxicology)
80% match

Integrin Targeting Systems for Tumor Diagnosis and Therapy (Methods in Pharmacology and Toxicology)

Humana

£69.37 22 Oct 2026
Checkpoint Controls and Targets in Cancer Therapy (Cancer Drug Discovery and Development)
80% match

Checkpoint Controls and Targets in Cancer Therapy (Cancer Drug Discovery and Development)

Humana

£111.28 30 Oct 2026
Death Receptors in Cancer Therapy (Cancer Drug Discovery and Development)
79% match

Death Receptors in Cancer Therapy (Cancer Drug Discovery and Development)

Humana

£80.67 23 Oct 2026
Apoptosis and Cancer Chemotherapy: 6 (Cancer Drug Discovery and Development)
79% match

Apoptosis and Cancer Chemotherapy: 6 (Cancer Drug Discovery and Development)

Humana

£79.12 10 Sep 2026
Cancer Gene Therapy (Contemporary Cancer Research)
79% match

Cancer Gene Therapy (Contemporary Cancer Research)

Humana

£166.07 24 Oct 2026
Cancer Drug Design and Discovery
79% match

Cancer Drug Design and Discovery

Academic Press

£84.99 24 Oct 2026